Murphy & Mullick Capital Management Corp
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2047271
SMITHTOWN, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$149,649
-$63,599 QoQ
Shares Held
240
-13.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,072
of 1,322 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Murphy & Mullick Capital Management Corp holds $1,730,688 across 5 Biotechnology names. REGN ranks #2 (8.6% of the industry book) .
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $149,649 | 240 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $213,248 | 276 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $216,895 | 281 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $202,417 | 360 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $196,350 | 374 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $272,718 | 430 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $316,274 | 444 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||